Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Atossa Therapeutics Inc (ATOS)

Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Atossa Therapeutics Inc 107 SPRING STREET SEATTLE WA 98104 USA

www.atossagenetics.com P: 206-325-6086 F: 206-902-9658

Description:

Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA.

Key Statistics

Overview:

Market Capitalization, $K 183,605
Enterprise Value, $K 95,035
Shares Outstanding, K 125,757
Annual Sales, $ 0 K
Annual Net Income, $ -30,090 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,880 K
EBIT, $ -31,260 K
EBITDA, $ -31,240 K
60-Month Beta 1.27
% of Insider Shareholders 7.80%
% of Institutional Shareholders 12.74%
Float, K 115,948
% Float 92.20%
Short Volume Ratio 0.44

Growth:

1-Year Return 67.82%
3-Year Return -54.66%
5-Year Return -42.97%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 95.64%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.05 on 05/13/24
Next Earnings Date 05/20/24
Earnings Per Share ttm -0.22
EPS Growth vs. Prev Qtr 16.67%
EPS Growth vs. Prev Year 0.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 04/20/18

ATOS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -32.79%
Return-on-Assets % -31.25%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.13
Book Value/Share 0.68
Interest Coverage -1.14
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar